Abstract
SOX17 promoter methylation can provide important prognostic information in cancer. We developed a novel semi-quantitative MS-HRMA assay for SOX17 promoter methylation. The assay was optimized by using synthetic control samples and validated by analyzing 165 clinical samples: a) 107 formalin fixed paraffin embedded (FFPEs) samples of patients with early breast cancer, b) 27 FFPE samples of patients with metastatic breast cancer, c) 15 reduction mammoplasty specimens obtained from healthy women and d) 16 genomic DNA samples isolated from healthy blood donors. Comparison with real time MSP was also performed. The assay is highly specific and sensitive and provides a semi-quantitative estimation of SOX17 promoter methylation. SOX17 promoter was found methylated in 96/134 (71.6%) breast cancer samples, while none of the 31 non-cancerous samples tested was positive (0%). SOX17 promoter methylation levels varied significantly among samples. When 165 clinical samples were analyzed both by MS-HRMA and real time MSP results were significantly comparable (concordance: 146/165, 88.5%). This novel MS-HRMA assay for SOX17 promoter methylation is closed-tube, highly sensitive, specific, cost-effective, rapid and easy-to-perform. It gives comp...Continue Reading
References
Aug 3, 2002·Oncogene·Manel Esteller
May 27, 2003·Clinical Chemistry·Carl T WittwerRobert J Pryor
Jun 24, 2003·Radiology·Harold L Kundel, Marcia Polansky
Jul 2, 2004·Clinical Chemistry·Michael LiewCarl Wittwer
Aug 17, 2004·Clinical Chemistry·Gudrun H Reed, Carl T Wittwer
Feb 10, 2007·Nucleic Acids Research·Tomasz K Wojdacz, Alexander Dobrovic
Jul 13, 2007·The International Journal of Biochemistry & Cell Biology·Véronique LefebvreBhattaram Pallavi
Apr 17, 2008·Cancer Research·Wei ZhangStephen B Baylin
May 2, 2008·Nucleic Acids Research·Cameron N GundryDavid H-F Teng
Aug 20, 2008·BMC Research Notes·Tomasz K WojdaczAlexander Dobrovic
Jan 31, 2009·Nature Protocols·Tomasz K WojdaczLise Lotte Hansen
Jun 2, 2009·Epigenetics : Official Journal of the DNA Methylation Society·Tomasz K WojdaczLise Lotte Hansen
Jun 25, 2009·Gastroenterology·Yu-Chen DuMasanobu Oshima
Jan 5, 2011·Clinical and Experimental Dermatology·W WuB Yu
Apr 25, 2012·Molecular Biology International·Wei MengTim Lautenschlaeger
May 10, 2012·Clinical Biochemistry·Rattaya AmornpisuttTemduang Limpaiboon
Oct 24, 2012·BMC Cancer·Lampros DimitrakopoulosEvi S Lianidou
Nov 9, 2012·Clinical Chemistry·Maria ChimonidouEvi S Lianidou
Feb 14, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Ioanna BalgkouranidouStylianos Kakolyris
Aug 24, 2013·Expert Review of Respiratory Medicine·Michael FleischhackerBernd Schmidt
Sep 5, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Benjamin GoeppertDieter Weichenhan
Dec 7, 2013·International Journal of Cancer. Journal International Du Cancer·Yu-Chih ChenHung-Cheng Lai
Dec 20, 2013·BMC Cancer·Quirinus J M VoorhamBeatriz Carvalho
Feb 13, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Zhujun XiaoXinying Wang
Mar 22, 2014·PloS One·Alfred HanselMatthias Dürst
Apr 11, 2014·Clinical Chemistry·Mei LiCarl T Wittwer
Jun 18, 2014·International Journal of Medical Sciences·I-Ying KuoYi-Ching Wang